FDA Will Not Appeal Ruling Against LDT Regulation, Giving a Big Victory to Labs
The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight
FDA-nir
Subscribe today for access to
Articles and Reports
Expanding Test Menus: A Compliance Roadmap for FDA-Regulated Labs
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
HHS Suddenly Dismantles CLIAC After 33 Years
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
FDA Sends 14 Warning Letters Regarding Cancer Products
From - National Intelligence Report
The U.S. Food and Drug Administration (FDA) continues to focus on direct-to-consumer marketing and sale of products and has issued warning letters in an effort to…
FDA Exempts Certain Class I Devices, Test Kits from 510(k) Filing
...
Already a member? Log in here
FDA Reports Advances in Diagnostics Development
From - National Intelligence Report
The U.S. Food and Drug Administration (FDA) recently unveiled its FY 2015-2016: Regulatory Science Progress Report. The report, the second of its kind under the Food and Drug Administration Safety and Innovation Act, says the…
23andMe Receives FDA Approval for DTC Genetic Test
...
Already a member? Log in here
FDA Reports “Significant Progress” in Diagnostics Development
...
Already a member? Log in here
Reports Indicate Faster FDA Approval Processes
...
Already a member? Log in here
Test Kits Included in Class 1 Devices Exempt from 510k Filing
From - National Intelligence Report
The FDA has determined that 71 device types, including some diagnostic test kits, should be exempt from 510k filings. These devices are deemed "sufficiently well understood and do not present risks that…
FDA Grants Approval for 23andMe DTC Genetic Test
From - National Intelligence Report
23andMe and the U.S. Food and Drug Administration (FDA) announced last week that the agency allowed marketing of 23andMe's Personal Genome Service Genetic Health Risk (GHR) tests for…
Flu Antigen Tests Reclassified as Class II Devices
...
Already a member? Log in here
FDA Discussion Paper Synthesizes Stakeholder Feedback on LDT Regulation
...
Already a member? Log in here